MedPath

The effects of Caffeine on Attentional Networks

Phase 4
Completed
Conditions
Cognition (Attention)
Neurological - Studies of the normal brain and nervous system
Registration Number
ACTRN12618000115235
Lead Sponsor
niversity of Tasmania
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
26
Inclusion Criteria

Participation will be restricted to low caffeine users (less than 100mg per day) as assessed by the Caffeine and energy drink questionnaire.

Exclusion Criteria

Exclusion criteria will include serious physical or neurological conditions, current or notable past history of mental health conditions), current use of psychoactive medications, recent or notable past history of illicit drug use, daily tobacco use, risk of alcohol dependence as measured by the Alcohol Use and Disorders Identification Test (AUDIT; defined as >= 16), high levels of psychological distress measured by Kessler Psychological Scale (K10; defined as >= 30), or contraindications to caffeine such as hypertension or anxiety. All participants will have English as their first language and normal or corrected-to-normal vision and hearing. Females will be excluded if they are currently pregnant or if there is any chance that they may be pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath